• 1
    Garg A, Fleckenstein JL, Peschok RM, Grundy SM. Perturbation of adipose tissue in patients with CGL. J Clin Endocrinol Metab 1992; 75: 358362.
  • 2
    Bjorntorp P, Brodoff BN. Obesity. New York: Lippincott Company; 1992.
  • 3
    Levin K, Schroeder DH, Alford FP, Beck-Nielsen H. Morphologic documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes. Diabetologia 2001; 44: 824833.
  • 4
    Boesch C, Slotboom J, Hoppeler H, Kreis R. In vivo determination of intra-myocellular lipids in human muscle by means of localized 1H-MR spectroscopy. Magn Reson Med 1997; 37: 484.
  • 5
    Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose-fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; I: 72857289.
  • 6
    Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH. β-cell lipotoxicity in the pathogenesis of non-insulin dependent diabetes. Proc Natl Acad Sci USA 1994; 91: 1087810882.
  • 7
    McGarry JD, Dobbins RL. Fatty acids lipotoxicity and insulin secretion. Diabetologia 1999; 42: 128138.
  • 8
    McGarry JD. Disordered metabolism in diabetes: have we underemphasized the fat component? J Cell Biochem 1994; 535: 2938.
  • 9
    Kelly DE, Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 2000; 49: 677683.
  • 10
    Schick F, Eismann B, Jung WI, Bongers H, Bunse M, Lutz O. Comparison of localized proton NMR signals of skeletal muscle and fat tissue in vivo: two lipid compartments in muscle tissue. Magn Reson Med 1993; 29: 158.
  • 11
    Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, McGarry JD, Stein DT. Measurement of intracellular stores by 1H spectroscopy: validation in liver and skeletal muscle. Am J Physiol 1999; 276: E977E989.
  • 12
    Krssak M, Petersen KF, Dresner A, Dipietro L, Vogel SM, Rothman DL, Shulman G, Roden M. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 1999; 42: 113116.
  • 13
    Jacob S, Macham J, Rett K, Brechtel K, Volk A, Renn W, Maerker E, Matthaei S, Schick F, Claussen CD, Haring HU. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offsprings of type 2 diabetic subjects. Diabetes 1999; 48: 11131119.
  • 14
    Perseghin G, Scifo P, De Cobelli F, Pagliato E, Battezzati A, Arcelloni C, Vanzulli A, Testolin G, Pozza G, Del Maschio A, Luzi L. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans. A 1H-13C NMR study. Diabetes 1999; 48: 16001606.
  • 15
    Chu SCK, Balschi JA, Springer CS. Bulk magnetic susceptibility schift in NMR studies of compartmentalized samples: use of paramagnetic reagents. Magn Reson Med 1990; 13: 239.
  • 16
    Hebel S, Kastrup EK. Intravenous fat emulsion. Drug facts and comparisons, updated monthly. St. Louis: Welter Kluwer Company; 2001. p 109110
  • 17
    Lide DR. Handbook of chemistry and physics. Boca Raton, FL: CRC Press; 1993.
  • 18
    Hwang YH, Pan JW, Heydari S, Stein DT. Regional differences in intramyocellular lipids in humans observed by in vivo1H MR spectroscopic imaging. J Appl Physiol 2001; 90: 12671274.